These non-promotional scientific presentations were presented at the medical congresses referenced below and are intended for U.S healthcare professionals who were in attendance for the purposes of scientific exchange.

These materials may contain information outside of the FDA approved label or relate to uses that have not been approved by the FDA. Syndax does not recommend use of Syndax products in any manner other than as described in the FDA-approved Prescribing Information.

Academy of Managed Care Pharmacy (AMCP)

Las Vegas, Nevada Apr 15 - 18, 2024

Results 1

Abstract | Apr 15, 2024

D18 Revumenib Monotherapy in Patients With Relapsed/Refractory KMT2Ar Acute Leukemia: Efficacy and Safety Results From the AUGMENT-101 Phase 1/2 Study

Aldoss I, et al.

View Material